ASCO & JCO Oncology Practice Overview

Working Together to Improve the Delivery of Cancer Care

The story of ASCO is the story of progress against cancer. There is currently tremendous clinical research being done to improve the lives of patients with cancer, and the U.S. cancer care delivery system is constantly changing to better meet the needs of patients. But despite rapid progress, major hurdles prevent patients from accessing the best, high-quality care.

As an integral member of ASCO’s portfolio of oncology publications, the JCO Oncology Practice (JCO OP) provides the tools for the practicing oncologist to navigate the ever-increasing complexity of the cancer care delivery system.

Filling an Important Role in Oncology

JCO OP (originally Journal of Oncology Practice) was launched in 2005 in response to the Medicare Modernization Act (MMA), which brought about a seismic shift in the health care landscape. The years since MMA have brought many legislative, economic, and administrative challenges to the practice of cancer care in the United States, challenges that oncologists and practice managers still grapple with today. Now, more than ever, oncologists need to stay abreast of the latest information and insights to keep their practices current and to continue to deliver high-quality care to cancer patients.

JCO OP is a unique oncology journal that bridges the gap between the clinical challenges of oncology and the mechanics of practice (also known as care delivery). All content dealing with understanding the provision of care is the purview of JCO OP. Additionally, JCO OP addresses the need of practicing physicians to have contemporary clinical problems discussed in a concise, accessible way. In 2020, Journal of Oncology Practice was brought under the JCO umbrella and re-named JCO Oncology Practice.

JCO OP Timeline of Important Events

A One-Two Punch – Editorial Covering the Business and Clinical Sides of Oncology

From the business of oncology, to health care policy, to the latest clinical and therapeutic advances, the editorial content of JCO OP offers concise, engaging insights into all aspects of oncology practice. The original research published in the journal covers topics that are indispensable to running a successful oncology practice, such as care delivery, reimbursement, health policy, business management, quality, and value of care. In addition, JCO OP provides focused, expert reviews that answer the pressing clinical concerns faced by oncologists every day.

Every issue of JCO OP includes:

• Practice-changing Original Contributions
• Insightful Editorials and Commentaries
• Focused, authoritative Clinical Reviews by thought leaders in oncology
• Practical summaries of the latest ASCO Guidelines

ReCAP = Research Contributions Abbreviated for Print

• Structured, accessible, one-page summaries clearly highlighting the main findings and significance of each Original Contribution.
• Increases the audience for each paper while optimizing the number of papers published in print.

State of the Oncology Workforce in America

In 2020, there will be an estimated 1.8 million new cancer cases in the United States and 16.9 million people living with a history of cancer.¹ As the demand for cancer services increases, it's especially important to monitor the workforce available to diagnose, treat, and continue to care for people with cancer. The 2020 Snapshot on the State of the Oncology Workforce in America provides highlights from the American Society of Clinical Oncology's (ASCO) Workforce Information System, which assembles the latest available data on oncologist supply and demand in the United States to provide a close look at a critical segment of the workforce who care for people with cancer. The 2020 Snapshot includes a special focus on the oncology workforce in rural America.

To read the full Workforce Information System report, visit asco.org/state-of-cancer-care

Sources

1. American Cancer Society: Cancer Facts and Figures 2020: www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2020.html;
2. Physician Compare datasets, Centers for Medicare & Medicaid Services: data.medicare.gov/data/physician-compare;
3. lbid;
4. AMA Physician Masterfile, American Medical Association: www.ama-assn.org/practice-management/masterfile/ama-physician-masterfile;
5. lbid;
6. Brotherton SE, Etzel SI. Graduate Medical Education, 2018-2019. JAMA. 2019;322(10):996-1016.;
7. Diversity in Medicine: Facts and Figures 2019, Association of American Medical Colleges: www.aamc.org/data-reports/workforce/report/diversity-medicine-facts-and-figures-2019;
8. lbid;
9. lbid;
10. Physician Compare datasets, Centers for Medicare & Medicaid Services: data.medicare.gov/data/physician-compare;
11. Rural-Urban Continuum Codes, United States Department of Agriculture: www.ers.usda.gove/data-products/rural-urban-continuum-codes.aspx;
12. Levit, Laura A et al. "Closing the Rural Cancer Care Gap: Three Institutional Approaches." JCO Oncology Practice, OP2000174. 23 Jun. 2020, doi:10.1200/OP.20.00174;
13. American Society of Clinical Oncology, 2019 National Cancer Opinion Survey: www.asco.org/sites/new-www.asco.org/files/content-files/blog-release/pdf/2019-ASCO-Cancer-Opinion-Survey-Final-Report.pdf

Circulation and Bonus Distribution

Circulation

*Includes dermatologists, musculoskeletal oncologists, biostatisticians, allied health care professionals, and other field-related personnel

Bonus Distribution*

*Bonus Distribution is subject to change and 2022 conferences may potentially change to a virtual setting

Print Advertising Rates

Black & White Rates

Insert Rates

Insert samples must be forwarded to Harborside prior to reservation deadline.

Net Rates Cover Tips Supplied

Outsert Pricing

Price based on 2-4 page outsert within specs

Contact your representative for more information

Color Charges

Premium Position Fees

*On 2nd and 3rd pages, up to 3 pages. For additional pages contact Harborside.

Frequency: 12× in 2022

Earned Rates: Each page or fraction thereof qualifies for earned annual contract frequency discounts for all affiliates of advertiser’s parent company.

Bleed: No charge

BRC Insert Charge

BRCs are billed as 1/2 page B&W inserts with minimum full-page ad opposite. A sample of the BRC and paper must be submitted to Harborside for approval.

List Match Charge

Harborside will match any client list to JCO OP’s circulation. The first 2 list matches are free; charge of $2,000 applies to all subsequent matches. If the client chooses to advertise to the selected audience through a demo insert, the appropriate demo charge will apply, and the initial list match fee will be waived. Maximum of 2 list matches per year per brand.

Split-Run Insert Charge

Billing is based on the earned insert rate times the percentage of circulation, with a minimum of 50% of the total circulation, plus a noncommissionable production charge of $2,500. For a run-of-book split-run charge, please contact Harborside.

Note: There is a maximum of 4 split-runs per issue.

All published rates are in USD

Print Discounts and Incentives

ASCO Publications Combined Frequency Rate

Advertisers in ASCO Publications: The ASCO Post, Journal of Clinical Oncology (JCO), and JCO Oncology Practice (JCO OP) combine for pages to earn the frequency rate in JCO OP as well as in all the ASCO publications. Space purchased by a parent company and subsidiaries is combined in calculating the earned rate. When the number of insertions is greater or less than indicated by the contract, rates are adjusted accordingly. Please contact Harborside for details. Frequency will be determined by the total number of pages placed in these publications during a calendar year.

PI Discount

Advertise 3 or more prescribing information (PI) pages for a single ad for a brand and receive a 50% discount on the B&W page rate beginning on the third PI page. Multi-journal discount is not eligible on discounted PI pages.

6-Time Discount

Advertise a product in 5 issues of JCO OP and receive the 6th FREE. If multiple sized ad units are placed in issues within a calendar year, the free ad unit will be determined by the average dollar amount spent per issue over the course of the year. This amount will be credited towards the last insertion of the year.

Two Publication Discount

Each individual product advertising in ASCO’s Journal of Clinical Oncology (JCO) OR The ASCO Post during the same month it advertises in ASCO’s JCO Oncology Practice (JCO OP) will receive a $400 per page discount in JCO OP and either a $200 discount in JCO or a $500 discount in The ASCO Post. Discount is based on the matching number of pages in The ASCO Post and JCO or JCO OP in a given month.

Total savings:

JCO OP + JCO = $600

JCO OP + TAP = $900

Print Advertising Guidelines

Agency Commission

Fifteen percent (15%) of gross billings on space, color, cover, and preferred position charges. Additional production charges are noncommissionable. Cash discounts are available.
Contact Harborside for details.

Advertising Policies

Placement of Advertising: Between, but not within, articles. Placement location is at the discretion of Harborside.

Publication Set Copy: With proofs, 30 days preceding publication month.

Disposal of Furnished Materials: Files not called for within 1 year will be deleted without notification.

Reprint Orders

For inquiries in the United States and Canada, please send your request to ReprintSolutions@wolterskluwer.com; for inquiries regarding reprint use in other countries, please send your request to InternationalReprints@wolterskluwer.com. To search for articles that support your messaging, please visit lwwreprints.ovidds.com.

Production Requirements

SWOP standards apply. All supplied ads should have registrations, center, and trim marks and should indicate issue date, page positioning, and other pertinent instructions on proofs and files. Contact Harborside before ad is due for additional specifications. Submit in PDF (X-1a) format CMYK. File and proof should include bleeds and trim.

All material should be supplied to the following specs. 1/8˝ will be trimmed on ALL sides.

Safety Margins for Live Matter:
1/2″ clear of all trim edges and the gutter

Journal Trim Size: 8-1/8″ × 10-7/8″

Type of Binding: Perfect

Print Advertising Specifications

Advertising Sizes

* with a 0.5″ safety down the middle

Requirements for Cover Tips, Inserts and Outserts

Two mockups must be provided for proposed piece. Mockups are needed to head off potential problems during binding and allow Harborside to provide feedback on how to correct any problems prior to delivery. Once samples are received, it will also be determined if additional postage and binding charges will be necessary. For a simple two-sided piece, a mockup is not necessary. All other configurations require mockups, which are due 4 weeks before due date to printer.

Material Storage

Files are held for 1 year and then destroyed, unless instructed otherwise in writing. Unused inserts will be destroyed 1 month after the issue mails.

Shipping

Closing Dates and Acceptance of Advertising

Closing Dates

Closing dates are subject to change. Supplement closing dates may vary.

Acceptance of Advertising

All advertising is subject to approval of the Editor-in-Chief, publisher, advertising representative, and ASCO. New advertisements are to be received by the publisher and advertising representative at least two weeks before the closing date. Please email all ad proofs to Norman W. Virtue at nvirtue@hbside.com. The publisher and advertising representative reserves the right to label any advertisement as such for any ads that contain significant editorial content or that look like editorial pages.

The advertiser and advertising agency accept and assume liability for all content (including text, representations, illustrations, opinions, and facts) of advertisements and their compliance with all applicable laws and regulations and also assume responsibility for any claims made against the publisher and advertising representative or ASCO arising from or related to such advertisements.

The advertiser and advertising agency recognize and accept that the following language appears within the publication: “The ideas and opinions expressed in JCO OP do not necessarily reflect those of ASCO. The mention of any product, service, therapy in this publication or in any advertisement in this publication should not be construed as an endorsement of the products mentioned.”

In the event that legal action or a claim is made against the publisher and advertising representative or ASCO arising from or related to such advertisements, the advertiser and advertising agency agree to fully defend, indemnify, and hold harmless the publisher, advertising representative and ASCO and to pay any judgment, expenses, and legal fees incurred by the publisher and advertising representative or ASCO as a result of said legal action or claim.

In addition, the publisher and advertising representative reserves the right to reject or discontinue any advertising for any reason. This right shall not be deemed to have been waived by acceptance or actual use of any advertising matter. The publisher and advertising representative reserves the right to label any advertisement as such for any ads that contain significant editorial content or that look like text pages. The publisher and advertising representative is not liable for delays in delivery and/or nondelivery due to any condition beyond the control of the publisher and advertising representative affecting production or delivery in any manner.

The publisher and advertising representative reserves the right to reject any advertising that it believes is not in keeping with the publication’s standards.

Advertiser and advertising agency agree to indemnify, defend, and hold harmless the publisher and advertising representative from any and all liability for content (including text, illustrations, representatives, sketches, maps, trademarks, labels, or other copyrighted matter) of advertisement printed or the unauthorized use of any person’s name or photography arising from the publisher’s reproduction and publishing of such advertisements pursuant to the advertiser’s or agency’s order.

ASCO Publication Network

All ASCO publication website impressions are now exclusively available through multi channel high SOV tumor specific segments.

Each segment includes behavioral (self identified ASCO specialists and/or high engagers of specific content) and contextually targeted impressions. Segments also include ROS impressions and ASCO e-newsletters.

Reaching this audience has never been more efficient!

• Ads served to self identified ASCO members and/or high engagers of specific content.
• Broad reach via ROS advertising
• E-mail based advertising
• Contextual targeted banners to disease specific content

New! Hyper-targeted segments now available

• Breast
• Colorectal
• Gastrointestinal
• Genitourinary
• Gynecologic
• Head & Neck
• Hematology
• Immunotherapy
• Informatics
• Leukemia
• Lung
• Lymphoma
• Melanoma
• Multiple Myeloma
• Practice Management
• Precision Oncology
• Rare Diseases
• Renal Cell
• Supportive Oncology
• And more...

Digital Advertising Opportunities and Custom Programs

View Ad Sizes and Placements

op.ascopubs.org

JCO OP 2021 Average Stats* U.S.

• Sessions Per Month: 24,000
• Users Per Month: 17,000
• Time on Site: 6:37
• Pageviews: 37,600
• Impressions Per Month: 122,000

*Based on U.S. average stats Oct 2021, Google Analytics, Google DFP, and MOAT Analytics.

JCO OP 2021 Average Stats* GLOBAL

• Sessions Per Month: 35,000
• Users Per Month: 25,000
• Time on Site: 2:20
• Pageviews: 58,000
• Impressions: 400,000

*Based on Global average stats Oct 2021, Google Analytics, Google DFP, and MOAT Analytics.

For rates and availability please contact your representative for details.

Ad Sizes Available

• Leaderboard: 728 x 90
• Medium Rectangle: 300 x 250
• Mobile Leaderboard: 320/300 x 50

View Ad Sizes and Placement

Digital Advertising Opportunities

View Ad Sizes and Placements

JCO OP e-TOCs

Five Emails for Every Issue of JCO OP

e-TOCs deploy weekly on Wednesdays and have content linking to the latest early-release articles published online in JCO OP, as well as the contents of each issue.

For rates and availability, please contact your representative for details.

JCO OP e-TOC Closing Dates

*Dates are subject to change.

Send all digital material to digitalads@hbside.com

Additional Advertising Opportunities

New! JCO - Journal of Clinical Oncology Resource Center

• The #1 Read Peer-Reviewed Oncology Publication
• Reach YOUR audience as they read topic specific content from JCO
• Contents include up to ten JCO Articles hand selected based on
  • Consumption habits
  • Latest research trends
  • Most read JCO articles
• Sponsorship includes:
  • 100% SOV advertising
  • Asset housing
  • NPI List Match

Best of JCO OP - ASCO Annual Meeting Edition

Digital Specifications

Additional Terms and Conditions

The publisher and advertising representative is not liable for delays in delivery and/or nondelivery in the event of an Act of God, action by any governmental or quasigovernmental entity, fire, flood, insurrection, riot, explosion, embargo, strikes (whether legal or illegal), labor or material shortage, transportation interruption of any kind, work slow-down, or any condition beyond the control of the publisher and advertising representative affecting production or delivery in any manner.

Insertion Order and Copy Regulations: Insertion instructions shall be supplied for every advertisement and shall clearly state the following information: name of publication, name of advertiser, date to be inserted, size of advertisement, identification of advertisement (proof of ad to be furnished if possible), plus any special instruction such as bleed and color.

Cancellation of space order forfeits the right to position protection.

The publisher’s and advertising representative’s liability for any error will not exceed the charge for the advertisement in question.

The publisher and advertising representative assumes no liability if for any reason it becomes necessary to omit an advertisement.

When change of copy, covered by an uncancelled insertion order, is not received by the closing date, copy run in the previous issue will be inserted.

Requests for specified position at ROB rates are given consideration, but no guarantee is made unless the position premium has been agreed to in the contract.

The publisher and advertising representative reserves the right to hold advertiser and/or its advertising agency jointly and severally liable for such monies as are due and payable to the publisher and advertising representative.

In the event that an advertiser is owed a credit as a result of adjustment of frequency rates, the publisher and advertising representative will provide credit only on future advertisements.

Payment Terms: Net 30 days of invoice date. Pre-payment discounts are available, contact publisher and advertising representative for more details.

Payment for New Advertisers: All new advertisers are required to prepay until credit and/or reference checks are completed. Once approved, Harborside payment terms are net 30 days. Contact the Harborside Finance Team at accounting@hbside.com for more details.

Viewability: 70% Viewability is current industry standard. Ads taking more than 3 seconds to load will not qualify for viewability makegoods. If there is a 10% difference between third-party reporting, a conversation ensues between client and Harborside.

Cancellation Policies

Print Cancellations

Cancellations in advertising by the advertiser or its agency may not be made after the closing date for the publication unless otherwise agreed to by both parties in writing.

Premium Position, Cover Tip, and Outsert Cancellations:

Cancellation must be made 60 days prior to the published issue closing date. After the published closing date, any premium position, cover tip, or outsert are non-cancelable, and full payment is due.

Please see Print Advertising Rates for list of premium positions

Digital Cancellations

In accordance with the AAAA/IAB Standard Terms and Conditions for Internet Advertising (Version 3.0) found at

https://www.iab.com/wp-content/uploads/2015/06/IAB_4As-tsandcs-FINAL.pdf

Advertiser may cancel the I/O as follows:

For Flat-Fee or Fixed Placements

• With minimum of 30 days prior written notice:
  no penalty
• With less than 30 days prior written notice: Advertiser is responsible for any contracted media to be served within 30 days
• IVT and Viewability Campaign requirements will not be honored on Flat-Fee (SOV) or Fixed Placements

For Website or CPM Placements

• With minimum of 14 days prior written notice: no penalty
• For a yearly buy, an advertiser can cancel twice with 14 days’ notice. All ensuing cancellations will require 30 days prior notice to avoid penalty charge

Contact

VP Publishing at ASCO
Angela Cochran

American Society of Clinical Oncology
2318 Mill Road, Suite 800, Alexandria, VA 22314
Tel: 571-483-1300 • www.asco.org

Associate Director
Miranda Walker
1-800-638-3030
miranda.walker@wolterskluwer.com

Harborside
94 North Woodhull Road, Huntington, NY 11743
Tel: 631-692-0800 • Fax: 631-692-0805 • www.hbside.com